Comparative Bioavailability Study of UDCA
NCT02385032 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2015-05-07
Summary
The purpose of this study is to evaluate bioavailability of two formulations of ursodiol.
Conditions
- Healthy
Interventions
- DRUG
-
Ursodiol
- DRUG
-
URSO Forte
Sponsors & Collaborators
-
Daewoong Pharmaceutical Co. LTD.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-02-28
- Primary Completion
- 2015-03-31
- Completion
- 2015-05-31
More Related Trials
-
Phase 2 Study of URC102 to Assess the Efficacy and Safety in Gout Patients
NCT02290210 ·Status: COMPLETED ·Phase: PHASE2
-
Role of Uralyt-U in Patients With Hyperuricemia
NCT04352153 ·Status: UNKNOWN ·Phase: NA
-
A Randomized Clinical Trail of The Effect of Postoperative Uric Acid Control on Stone Recurrence and Renal Function in Patients With Hyperuricemia of Urolithiasis.
NCT04398251 ·Status: UNKNOWN ·Phase: PHASE4
-
Study of the Correlation Between UltraSonography and Dual-Energy Computed Tomography Assessment of Urate Deposit
NCT03162341 ·Status: COMPLETED ·Phase: NA
-
Association Between Uric Acid and Acute Coronary Syndrome
NCT05770323 ·Status: UNKNOWN
-
The Relationship Among, Serum Uric Acid, Left Ventricular Hypertrophy and Metabolic Syndrome
NCT03473951 ·Status: UNKNOWN
-
A Study of RDEA806 in Hyperuricemic Subjects With Symptomatic Gout
NCT00741442 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating the Effect of Digoxin and Ursodeoxycholic Acid in Patients With Rheumatoid Arthritis
NCT04834557 ·Status: COMPLETED ·Phase: PHASE2
-
Gout Dose Response Study
NCT00955981 ·Status: COMPLETED ·Phase: PHASE2
-
Study of FYU-981 in Hyperuricemia (Effect on Two Hyperuricemic Types)
NCT02837198 ·Status: COMPLETED ·Phase: PHASE2
-
Urate Lowering Therapies and Left Ventricular Diastolic Dysfunction
NCT03534037 ·Status: UNKNOWN ·Phase: PHASE4
-
Study of FYU-981 in Hyperuricemic Outpatients With or Without Gout (Effect on Two Hyperuricemic Types)
NCT03375632 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Hyperuricemia Reversal on Features of the Metabolic Syndrome
NCT01654276 ·Status: COMPLETED ·Phase: PHASE4
-
Study of FYU-981 in Hyperuricemia With or Without Gout
NCT02344862 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability and Pharmacokinetic/Pharmacodynamic Characteristics of LC350189
NCT01361646 ·Status: COMPLETED ·Phase: PHASE1
-
Low-dose Colchicine With or Without Stepwise Dose Titration of Febuxostat for Flare Prophylaxis in Gout
NCT04697602 ·Status: TERMINATED ·Phase: NA
-
Lowering-hyperuricemia Treatment on Cardiovascular Outcomes in Peritoneal Dialysis Patients
NCT03200210 ·Status: UNKNOWN ·Phase: PHASE4
-
Tolerance, Pharmacokinetics / Pharmacodynamics (PK / PD) and Immunogenicity of Pegylated Uric Acid Oxidase for Injection in Healthy Adults and Hyperuricemia Volunteers
NCT05226013 ·Status: UNKNOWN ·Phase: PHASE1
-
Effect of Hyperuricaemia on Chronic Renal Disease
NCT03425708 ·Status: UNKNOWN ·Phase: PHASE4
-
Mild, Moderate and Severe Renal Impairment Study
NCT02219516 ·Status: COMPLETED ·Phase: PHASE1
-
The Relationship Between Uric Acid and Inflammatory Markers
NCT01323335 ·Status: COMPLETED ·Phase: PHASE1
-
Maintenance or Withdrawal of Urate Lowering Therapy According to Ultrasound Features in Gout Patients: a Randomised Controlled Trial Stop Treatment In Gout
NCT06956885 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Controlled Study of Uric Acid on the Progression of IgA Nephropathy
NCT00793585 ·Status: COMPLETED ·Phase: NA
-
Pathophysiology of Uric Acid Nephrolithiasis
NCT00904046 ·Status: COMPLETED ·Phase: NA
-
Drug Use Study of Febuxostat After Recent Changes in the Prescribing Information
NCT04853160 ·Status: COMPLETED